American journal of surgery · 2025
Statewide episode spending variation of thyroidectomy for lower-risk thyroid cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jensen Catherine B, Xie Steven, Sinha Aayushi, Bacon Elizabeth M, Underwood Hunter J, Nathan Hari, Pitt Susan C
Аннотация
BACKGROUND: This study aimed to evaluate variation in spending for thyroidectomy for patients with thyroid cancer.
METHODS: This retrospective cohort study analyzed risk-adjusted, price-standardized Michigan-based claims data from 2015 to 2022 and included patients who underwent thyroidectomy for lower-risk thyroid cancer. The primary outcome was 90-day spending. A mixed linear model with facility as a random effect identified factors associated with spending variability.
RESULTS: In total, 2516 patients underwent thyroidectomy at 81 facilities. Unadjusted 90-day spending ranged from $5917 to $25,630 across facilities (median $8993). Spending was lowest for lobectomy (median $7755) and highest for lobectomy followed by completion thyroidectomy (median $14,181). On regression, factors significantly associated with increased spending were patient age and readmission. The interaction between occurrence of post-operative complications and lengths of stay >2 nights contributed to dramatically higher spending.
CONCLUSIONS: Reducing complications and associated length of stay as well hospital readmissions represent opportunities to improve the value of thyroidectomy.
METHODS: This retrospective cohort study analyzed risk-adjusted, price-standardized Michigan-based claims data from 2015 to 2022 and included patients who underwent thyroidectomy for lower-risk thyroid cancer. The primary outcome was 90-day spending. A mixed linear model with facility as a random effect identified factors associated with spending variability.
RESULTS: In total, 2516 patients underwent thyroidectomy at 81 facilities. Unadjusted 90-day spending ranged from $5917 to $25,630 across facilities (median $8993). Spending was lowest for lobectomy (median $7755) and highest for lobectomy followed by completion thyroidectomy (median $14,181). On regression, factors significantly associated with increased spending were patient age and readmission. The interaction between occurrence of post-operative complications and lengths of stay >2 nights contributed to dramatically higher spending.
CONCLUSIONS: Reducing complications and associated length of stay as well hospital readmissions represent opportunities to improve the value of thyroidectomy.